Evidence map›Paper›PMID 37046518›Full record

ArticleDiagnostics (Basel, Switzerland)2023

The Impact of the

Snežana Minić, Nataša Cerovac, Ivana Novaković, Slobodan Gazikalović, Svetlana Popadić, Dušan Trpinac

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. EvaluatingMedicina (Kaunas, Lithuania) · 2024
    Article
  3. Bioinformatic Analysis ofInternational journal of molecular sciences · 2024
    Article
  4. Case Report: Diagnosis and treatment ofFrontiers in pediatrics · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Snežana MinićClinic of Dermatovenerology, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Deligradska 34, 11000 Belgrade, Serbia.ORCID 0000-0003-2185-9749
Nataša CerovacClinic for Neurology and Psychiatry for Children and Youth, University Clinical Center of Serbia, Dr. Subotica 6a, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Ivana NovakovićInstitute of Human Genetics, Faculty of Medicine, University of Belgrade, Višegradska 26, 11000 Belgrade, Serbia.
Slobodan GazikalovićInstitute for Mother and Child Healthcare of Serbia "Dr Vukan Čupić", Radoja Dakića 8, 11070 Belgrade, Serbia.
Svetlana PopadićClinic of Dermatovenerology, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Deligradska 34, 11000 Belgrade, Serbia.
Dušan TrpinacInstitute of Histology and Embryology, Faculty of Medicine, University of Belgrade, Višegradska 26, 11000 Belgrade, Serbia.
University of Belgrade · RSInstitute of Public Health of Serbia · RS

Funding

Ministry of Education, Sciences and Technological Development of The Republic of Serbia 175005
6 · The paper itself

Abstract

Incontinentia pigmenti (IP) is a rare skin disease combined with anomalies of the teeth, eyes, and central nervous system (CNS). Mutations of the

Indexed as

central nervous system (CNS)corpus callosumIKBKG gene mutationincontinentia pigmentimagnetic resonance imaging (MRI)whole exome sequencing (WES)X-chromosome inactivation

Identifiers

PMID37046518
PMCPMC10093331
OpenAlexW4361267546

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.